ARTICLE | Clinical News

ProtAffin preclinical data

October 11, 2010 7:00 AM UTC

In mouse models of lipopolysaccharide (LPS)-induced lung inflammation and sub-chronic smoke exposure, PA401 displayed "strong and broad" anti-inflammatory activity as compared to Daxas roflumilast and SCH527123, while also reducing levels of the murine homologs of IL-8. Data were presented at the European Respiratory Society meeting in Barcelona. The company plans to start Phase I testing of the modified form of human IL-8 in early 2012. ...